MAIA Biotechnology, Inc. (MAIA)
1.31
-0.02
(-1.50%)
USD |
NYAM |
Aug 31, 16:00
1.30
-0.01
(-0.76%)
After-Hours: 20:00
MAIA Biotechnology Cash from Operations (TTM) : -22.57M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.57M |
| March 31, 2026 | -19.95M |
| December 31, 2025 | -18.84M |
| September 30, 2025 | -15.73M |
| June 30, 2025 | -15.77M |
| March 31, 2025 | -16.32M |
| December 31, 2024 | -15.70M |
| September 30, 2024 | -15.79M |
| June 30, 2024 | -15.42M |
| March 31, 2024 | -13.30M |
| Date | Value |
|---|---|
| December 31, 2023 | -13.07M |
| September 30, 2023 | -11.59M |
| June 30, 2023 | -12.75M |
| March 31, 2023 | -12.47M |
| December 31, 2022 | -11.66M |
| September 30, 2022 | -10.75M |
| June 30, 2022 | -7.746M |
| March 31, 2022 | -6.415M |
| December 31, 2021 | -4.123M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.681B |
| TG Therapeutics, Inc. | 17.88M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |